Impedimed (Australia) Insiders

Impedimed Management Team Effectiveness

The company has return on total asset (ROA) of (0.3244) % which means that it has lost $0.3244 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7589) %, meaning that it generated substantial loss on money invested by shareholders. Impedimed's management efficiency ratios could be used to measure how well Impedimed manages its routine affairs as well as how well it operates its assets and liabilities. Impedimed has a total of 2.04 Billion outstanding shares. Impedimed retains 11.25 (percent) of its outstanding shares held by insiders and 15.25 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Impedimed Workforce Comparison

The company has Profit Margin (PM) of (1.83) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.7) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.7.

Impedimed Benchmark Summation

Impedimed Notable Stakeholders

String symbol = request.getParameter("s");

The success or failure of an entity such as Impedimed often depends on how effective the management is. Impedimed management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Impedimed management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Impedimed management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Impedimed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Impedimed. Check Impedimed's Beneish M Score to see the likelihood of Impedimed's management manipulating its earnings.

When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.